Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › belimumab

belimumab

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of belimumab

18 trials tracked of belimumab: 7 in phase 3 or 4 and 6 with published results. The most-cited published study has 111 citations.

18Trials tracked
7Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 1 Phase 3 6 Phase 2 8 Phase 1 3
  1. Phase 3 A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE Completed · 111 cited
  2. Phase 3 A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 Completed · 84 cited
  3. Phase 3 GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia Completed · 41 cited
  4. Phase 3 Belimumab in Idiopathic Inflammatory Myositis Completed · 28 cited
  5. Phase 3 BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 Completed · 22 cited
  6. Phase 3 Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients Completed · 11 cited
Show 12 more trials
  1. Phase 4 Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) Completed
  2. Phase 2 A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy Completed
  3. Phase 2 Rituximab and Belimumab for Lupus Nephritis Completed
  4. Phase 2 Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome Completed
  5. Phase 2 The Evaluation of Belimumab in Myasthenia Gravis (MG) Completed
  6. Phase 2 Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Completed
  7. Phase 2 A Study of Belimumab in the Prevention of Kidney Transplant Rejection Completed
  8. Phase 2 Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies Completed
  9. Phase 2 A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 Completed
  10. Phase 1 A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus Completed
  11. Phase 1 Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation Completed
  12. Phase 1 Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus Completed

Showing the 18 most-cited and recently-updated of 18 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Core set domains capture SLE treatment response in 89.5% of cases at week 52
Rheumatology RCT
Core set domains capture SLE treatment response in 89.5% of cases at week 52 Core set domains capture most lupus disease activity in a global trial
This phase III randomized controlled trial evaluated subjects with Systemic Lupus Erythematosus across a global setting. The study compared …
A global trial found that a core set of domains captured most lupus disease activity without missing important patient responses.
May 22, 2026
Network meta-analysis compares biologics and targeted drugs for systemic lupus erythematosus efficacy and safety
Infectious Disease Meta-analysis
Network meta-analysis compares biologics and targeted drugs for systemic lupus erythematosus efficacy and safety New Lupus Treatments Show Stronger Results With Fewer Side Effects
This systematic review and network meta-analysis of 17,121 patients with systemic lupus erythematosus compared biologics and targeted small …
Certain new lupus drugs help more people feel better with fewer flare-ups, especially those struggling with rashes or joint pain that older …
Frontiers May 2, 2026
Meta-analysis of belimumab versus anifrolumab in systemic lupus erythematosus and lupus nephritis
Rheumatology Meta-analysis
Meta-analysis of belimumab versus anifrolumab in systemic lupus erythematosus and lupus nephritis Belimumab and anifrolumab show different strengths for lupus patients
This meta-analysis compared belimumab and anifrolumab using indirect evidence from randomized controlled trials involving 4332 patients with…
A new analysis compares two lupus drugs. Belimumab worked better for overall disease control, while anifrolumab helped lower steroid doses a…
May 1, 2026